PDAC tumor organoids (IMAGE)
Caption
CSHL’s Krainer lab has discovered a key oncogenic circuit driving aggressive pancreatic ductal adenocarcinoma (PDAC) progression. Using human PDAC tumor organoids, seen here, the team developed a potential RNA splicing-based therapeutic that collapses the circuit.
Credit
Krainer lab/CSHL
Usage Restrictions
Attribution required
License
Licensed content